Status:
UNKNOWN
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI
Lead Sponsor:
University of Pisa
Collaborating Sponsors:
Azienda Ospedaliero, Universitaria Pisana
Imago 7
Conditions:
Liver Cirrhosis
Liver Steatosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aim of this study is to evaluate the correlation between the characteristics detected by the 7T MRI equipment and the histological composition of native explanted livers (group A), liver graft exclude...
Eligibility Criteria
Inclusion
- GROUP A of Native Liver
- informed consent
- full possession of one's faculties
- patients who are going to undergo liver transplantation, independently from previous therapy or from the primary disease they are affected by.
Exclusion
- patients affected by polycystic liver disease
- excluded from liver transplantation.
- GROUP B of Excluded Grafts
- Inclusion Criteria:
- \- liver grafts with histologically proven macrovescic steatosis, not fit for transplantation
Key Trial Info
Start Date :
May 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04012021
Start Date
May 24 2019
End Date
December 31 2020
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero Universitaria Pisana
Pisa, PI, Italy, 56124